KURA
KURA
NASDAQ · Biotechnology

Kura Oncology Inc

$11.73
+0.01 (+0.09%)
As of Sep 20, 10:21 PM ET ·
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 19 86%
Hold 3 14%
Sell 0 0%
Price Target
Analyst Price Target +291.5% upside
Low Target $25.11
Average Target $45.92
High Target $52.51
Current Price $11.73
Current
$11.73
Target
$45.92
$25.11 $45.92 avg $52.51
Scenario Analysis
Bear Case
$25.11
114.1%
Low target
Base Case
$45.92
+291.5%
Avg target
Bull Case
$52.51
+347.7%
High target
Risk/Reward
3.0x
Highly favorable
Price in Context
52-Week High
$13.90
-15.6% from high
52-Week Low
$7.36
+59.4% from low
Target vs 52W High
$45.92
+230.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.8%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +139.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -15.1%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -17.9%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.2%